tiprankstipranks
Morgan Stanley, Comerica upgraded: Wall Street’s top analyst calls
PremiumThe FlyMorgan Stanley, Comerica upgraded: Wall Street’s top analyst calls
11d ago
Regeneron, Sanofi announce FDA accepts Dupixent sBLA for review
Premium
The Fly
Regeneron, Sanofi announce FDA accepts Dupixent sBLA for review
11d ago
Wolfe Research starts Regeneron at Outperform, sees ‘attractive entry point’
Premium
The Fly
Wolfe Research starts Regeneron at Outperform, sees ‘attractive entry point’
12d ago
Regeneron price target lowered to $1,000 from $1,150 at Oppenheimer
PremiumThe FlyRegeneron price target lowered to $1,000 from $1,150 at Oppenheimer
20d ago
Regeneron, Sanofi announce EC approval for Dupixent
Premium
The Fly
Regeneron, Sanofi announce EC approval for Dupixent
20d ago
Regeneron price target lowered to $1,126 from $1,137 at Truist
Premium
The Fly
Regeneron price target lowered to $1,126 from $1,137 at Truist
25d ago
Regeneron price target lowered to $1,065 from $1,080 at Barclays
PremiumThe FlyRegeneron price target lowered to $1,065 from $1,080 at Barclays
25d ago
Regeneron Pharmaceuticals Reports Strong Q3 2024 Results
Premium
Company Announcements
Regeneron Pharmaceuticals Reports Strong Q3 2024 Results
25d ago
Regeneron files automatic mixed securities shelf
Premium
The Fly
Regeneron files automatic mixed securities shelf
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100